Versions Compared

Old Version 14

changes.mady.by.user Paula

Saved on

compared with

New Version 15

changes.mady.by.user Kerry Robson

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope 

  • Clarify definitions and labels.
  • Experience sharing of methodologies used to set thresholds for QTL parameters with a clear link to the scientific question of the clinical trial.
  • Develop a guidance for threshold-setting methodologies for QTL parameters with a clear link to the scientific question of the clinical trial.



Project LeadsEmail
Nathalie van Borrendam(Janssen Research & Development) nvanborr@its.jnj.com
Annett Keller(Boehringer Ingelheim) annett.keller@boehringer-ingelheim.com
Paula Rowley(PHUSE Project Assistant)

paula@phuse.global


Objectives & DeliverablesTimelines
Challenges in QTL threshold setting – Experience sharing and high-level recommendations for the industryQ3 2022

Guidance document on QTL threshold-setting methodologies

Q1 2023


Status
colourBlue
titleCurrent Status
Q3/4 2022

During the PHUSE EU Connect,Working Group members will meet to kickoff the white paper.



Project MembersOrganisations
Annett KellerBoehringer Ingelheim
Debra JendrasekDaiichi Sankyo
Jim WangJanssen Research & Development
Marcus EeMaithy MuliMerck
Marion WolfsJanssen Research & Development
Nathalie van BorrendamJanssen Research & Development
Patrice BennerMerck
Stefano SainoMerck
Steve YoungCluePoints
Steven Andrew GilbertPfizer
Susan TalbotAmgen